As techniques have been refined, interest in personalized mouse models of disease has risen, writes Andrew Pollack at The New York Times. While the use of such avatars has not been proven to affect patient outcomes and is expensive, Pollack says that some cancer patients are still trying that approach to learn more about how their cancers, implanted into mice, react to different drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Very Own Mouse

The Mouse Version

The Healthiest

This Week in Cell

Order Matters

Fido's Prescription

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.